In patients in whom warfarin therapy is withheld in the periprocedural period but who are considered to be at high risk of thromboembolic events, clinicians often instigate heparin 'bridging'.

Purpose. A possible role for fondaparinux as a bridging agent in the perioperative setting is explored. Summary. Anticoagulation guidelines provide minimal direction on the perioperative use of ...